Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Yun Ma

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|September 19, 2017
[Meta-analysis on efficacy of Fuke Qianjin tablets (capsules) combined with antibiotics in treatment of endometritis]Li Wang, Rui Xu, Shao-Hua Zhang, et al.
British Journal of Haematology|May 4, 2021
A prognostic immune risk score for diffuse large B-cell lymphomaShu-Yun Ma, Xiao-Peng Tian, Jun Cai, et al.
Journal of Digestive Diseases|November 16, 2023
Development and validation of a scoring system to predict esophagogastroduodenoscopy necessityJing Yang, Jing Shuang Yan, Cen Xi Xiong, et al.
Zhonghua Yi Xue Za Zhi|February 11, 2012
[Effects of receptor interacting protein 140 on the biological activity of glia cells]Li-na Xie, Wei-dong Yu, Rong Liang, et al.
Annals of Hematology|April 15, 2020
Upfront autologous stem cell transplantation for untreated diffuse large B cell lymphoma patients in rituximab era: a systematic review and meta-analysisShu-Yun Ma, Xiao-Peng Tian, Jun Cai, et al.
Cancer Communications (London, England)|May 28, 2020
BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T-cell lymphoblastic lymphomaXiao-Peng Tian, Jun Cai, Shu-Yun Ma, et al.
British Journal of Haematology|October 7, 2021
Combination of PD-1 inhibitor with GVD (gemcitabine, vinorelbine, liposomal doxorubicin) versus GVD regimen as second-line therapy for relapsed/refractory classical Hodgkin lymphomaYu-Chen Zhang, Jin-Ni Wang, Shu-Yun Ma, et al.
Blood|March 17, 2021
A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphomaXiao-Peng Tian, Shu-Yun Ma, Ken H Young, et al.
Cell Reports. Medicine|February 22, 2023
Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphomaXiao-Peng Tian, Yu-Chen Zhang, Ning-Jing Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2020
A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic LymphomaXiao-Peng Tian, Ning Su, Liang Wang, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|September 19, 2017
[Meta-analysis on efficacy of Fuke Qianjin tablets (capsules) combined with antibiotics in treatment of endometritis]Li Wang, Rui Xu, Shao-Hua Zhang, et al.
British Journal of Haematology|May 4, 2021
A prognostic immune risk score for diffuse large B-cell lymphomaShu-Yun Ma, Xiao-Peng Tian, Jun Cai, et al.
Journal of Digestive Diseases|November 16, 2023
Development and validation of a scoring system to predict esophagogastroduodenoscopy necessityJing Yang, Jing Shuang Yan, Cen Xi Xiong, et al.
Zhonghua Yi Xue Za Zhi|February 11, 2012
[Effects of receptor interacting protein 140 on the biological activity of glia cells]Li-na Xie, Wei-dong Yu, Rong Liang, et al.
Annals of Hematology|April 15, 2020
Upfront autologous stem cell transplantation for untreated diffuse large B cell lymphoma patients in rituximab era: a systematic review and meta-analysisShu-Yun Ma, Xiao-Peng Tian, Jun Cai, et al.
Cancer Communications (London, England)|May 28, 2020
BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T-cell lymphoblastic lymphomaXiao-Peng Tian, Jun Cai, Shu-Yun Ma, et al.
British Journal of Haematology|October 7, 2021
Combination of PD-1 inhibitor with GVD (gemcitabine, vinorelbine, liposomal doxorubicin) versus GVD regimen as second-line therapy for relapsed/refractory classical Hodgkin lymphomaYu-Chen Zhang, Jin-Ni Wang, Shu-Yun Ma, et al.
Blood|March 17, 2021
A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphomaXiao-Peng Tian, Shu-Yun Ma, Ken H Young, et al.
Cell Reports. Medicine|February 22, 2023
Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphomaXiao-Peng Tian, Yu-Chen Zhang, Ning-Jing Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2020
A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic LymphomaXiao-Peng Tian, Ning Su, Liang Wang, et al.
Pageof 2